Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Important differences between topoisomerase-I and -II targeting agents

Shantanu Banerji1, Marek Los

  • 1Manitoba Institute of Cell Biology, Winnipeg, Manitoba, Canada.

Cancer Biology & Therapy
|September 14, 2006
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Life Years Gained and Healthcare Dollars Saved: National Economic Evidence Supporting Comprehensive Genomic Profiling as Standard of Care for Canadian Cancer Patients.

Current oncology (Toronto, Ont.)·2026
Same author

A Real-World Analysis of Outcomes in CIC-Rearranged Sarcomas: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) Study.

Cancer medicine·2026
Same author

Toward Timely and Equitable Advanced Biomarker Testing for Patients with Metastatic Cancer in Canada.

Current oncology (Toronto, Ont.)·2025
Same author

Cannabidiol Vaping-Associated Multifocal NSCLC in a 24-Year-Old Female: A Case Report.

JTO clinical and research reports·2025
Same author

The continually evolving landscape of novel therapies in oncogene-driven advanced non-small-cell lung cancer.

Therapeutic advances in medical oncology·2025
Same author

Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer Under-Represented by Clinical Trials.

Current oncology (Toronto, Ont.)·2024